Announcements Call for applications by The Migration Health South Asia Network for skill & capacity development training workshop to be held in 6-9 April 2020   |   Open Letter: Stop the war on Syria’s hospitals

More questions than answers

A Mohan

DOI: 10.20529/IJME.2011.074


The past two decades have seen the emergence of third world countries as important sites for drug trials and related clinical research sponsored by the pharmaceutical industry. As the authors of the report under review have noted, “fast recruitment of trial participants, presence of a broad spectrum of diseases, availability of human resources and technical skills, different ethnic responses to drugs and the availability of treatment naïve population” are powerful drivers of thisphenomenon. In addition to such off-shoring, the authors have also drawn attention to outsourcing of trials to clinical research organisations (CROs). Considering the potential for abuse of rights and ethical deviations, such a study of this phenomenon was a pressing need.

Full Text





There are currently no refbacks.

Article Views

PDF Downloads

Click here to support US